The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians…
Continue ReadingCategory: Gastric Healthcare
FDA Approves First-in-Class Drug for Gastric Cancer
The FDA has approved Vyloy (zolbetuximab-clzb) as a first-line treatment of adults with locally advanced unresectable…
Continue ReadingTeleflex Announces Publication of a Propensity Matching
Retrospective data from the largest comparative case series of patients undergoing laparoscopic sleeve gastrectomy (LSG) with…
Continue Reading
RNT Health Insights’ gastric cancer tool gets breakthrough device designation
RNT Health Insights’ early gastric cancer detection tool has a 96% accuracy rate. Credit: SofikoS /…
Continue Reading
Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Junction Cancer
A new targeted cancer treatment, given in combination with a standard chemotherapy, for adults with stomach…
Continue Reading
Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment
Astellas Pharma’s Vyloy (zolbetuximab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA)…
Continue Reading